Iodide

Iodide

SCHEMBL2872084

I.[HH].[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL9131250 0.82
SCHEMBL10388761 0.82
Iodide SCHEMBL60665 0.82
SCHEMBL11631041 0.82
SCHEMBL11633001 0.82
SCHEMBL11629843 0.82
Iodide SCHEMBL7922251 0.82
SCHEMBL3963314 0.82
Iodide SCHEMBL21530823 0.82
Iodide SCHEMBL9632840 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476223-B2 REACTING N-(3-(3-(DIMETHYLAMINE)-OXO-2-PROPENYL)PHENYL) ACETAMIDE WITH ETHYL IODIDE IN THE PRESENCE OF SODIUM HYDRIDE IN DIMETHYLFORMAMIDE; DILUTING (N-(3-(3-(DIMETHYLAMINE)-1-OXO-2-PROPENYL)ACETAMIDE GADOR S. A. (AR) 2002-11-05 US claimed
US-20020072605-A1 Method for obtaining N-[3(3-cyano-pyrazole[1,5-a]pyrimidine-7-yl)phenyl]-N-ethyl-acetamide GADOR S.A. (AR) 2002-06-13 US claimed
CN-111819184-B Synthetic oligosaccharide derivatives as vaccine against bordetella pertussis 芬兰疫苗研究所 2024-01-12 CN disclosed
CN-111819184-A Synthetic oligosaccharide derivatives as vaccines against bordetella pertussis 芬兰疫苗研究所 2020-10-23 CN disclosed
US-RE47475-E1 Selective agents for pain suppression WISYS TECHNOLOGY FOUNDATION, INC. (US) 2019-07-02 US disclosed
CN-103483236-B Prepare method and the intermediate of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives 诺华股份有限公司 2016-09-28 CN disclosed
US-8835424-B2 Selective agents for pain suppression WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-09-16 US disclosed
CN-103483236-A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives NOVARTIS AG 2014-01-01 CN disclosed
CN-101952249-B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives NOVARTIS AG 2013-10-16 CN disclosed
CN-101952249-A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives NOVARTIS AG 2011-01-19 CN disclosed
US-20100317619-A1 Selective Agents for Pain Suppression COOK JAMES 2010-12-16 US disclosed
EP-1294702-A1 BENZODIAZEPINE DERIVATIVES AS APP MODULATORS MERCK SHARP &amp; DOHME LTD. (GB) 2003-03-26 EP disclosed
WO-2001090084-A1 BENZODIAZEPINE DERIVATIVES AS APP MODULATORS MERCK SHARP & DOHME LIMITED (GB) 2001-11-29 WO disclosed
US-5952321-A Substituted azetidinones as anti-inflammatory and antidegenerative agents MERCK & CO., INC. (US) 1999-09-14 US disclosed
EP-0666846-A4 1995-09-20 EP disclosed
EP-0666846-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO. INC. (US) 1995-08-16 EP disclosed
WO-1994010143-A1 NEW SUBSTITUTED AZETIDINONES AS ANTI-INFLAMMATORY AND ANTIDEGENERATIVE AGENTS MERCK & CO., INC. (US) 1994-05-11 WO disclosed
WO-1992013451-A1 IMIDAZOLE PESTICIDES SCHERING AGROCHEMICALS LIMITED (GB) 1992-08-20 WO disclosed
US-5081313-A PROCESS FOR THE PREPARATION OF 2,3-DIALKOXYPROPANALS BASF AKTIENGESELLSCHAFT (DE) 1992-01-14 US disclosed
US-4186142-A Cyclization substrates and 6α-substituted 19-norsteroid derivatives AKZONA INCORPORATED (US) 1980-01-29 US disclosed